Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Idea to Innovation

University of British Columbia

$14,950.00

Market Assessment for a Palladium Membrane Deuteration Reactor

FY 2019-20

Summary
Our team is developing an electrochemical reactor that leverages the unique properties of a thin palladium membrane to perform reductive deuteration on organic substrates. Our reactor is favourable compared to known synthetic methods because: i) the reactor uses benign reagents; ii) the reactions proceed at room temperature and pressure; iii) the products are produced quantitatively; iv) the reaction is site-selective for certain bonds; v) no product separation is required. This system has the potential to benefit to the pharmaceutical industry because deuteration of a drug can slow the metabolism of a bioactive molecule and increase the overall efficacy. This link between deuteration and the properties for bio-active molecules is established, and the United States Food and Drug Administration approved the first deuterated drug, deutetetrabenazine, in 2017. Several other deuterated versions of common drugs are currently in phase II and III clinical trials. This proposal outlines our plan to undertake a market study in conjunction with UBC's University Industry Liaison Office and Adventus Research Consultants (Guelph, ON) to better understand the market potential of our invention. This study will encompass both primary and secondary research. The final deliverable will be a report from Adventus that informs our commercialization strategy as we develop the technology.
Program
Idea to Innovation
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
538497-2019
Name nom
Berlinguette, Curtis
Department département
Chemistry
Organization id
2
Institution établissement
University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2019
Competition year année de concours
2019
Award amount
14950
Program id
I2IPJ
Program name en
Idea to Innovation
Program name fr
De l'idée à l'innovation
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1208
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Materials sciences
Area of application fr
Sciences des matériaux
Research subject code
3704
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Synthetic methodology
Research subject fr
Méthodologie en synthèse
Installment
inst:1 - 1
Partie
1
Nb partie
1
Application title
Market Assessment for a Palladium Membrane Deuteration Reactor
Keyword
NSERC
Application summary
Our team is developing an electrochemical reactor that leverages the unique properties of a thin palladium membrane to perform reductive deuteration on organic substrates. Our reactor is favourable compared to known synthetic methods because: i) the reactor uses benign reagents; ii) the reactions proceed at room temperature and pressure; iii) the products are produced quantitatively; iv) the reaction is site-selective for certain bonds; v) no product separation is required. This system has the potential to benefit to the pharmaceutical industry because deuteration of a drug can slow the metabolism of a bioactive molecule and increase the overall efficacy. This link between deuteration and the properties for bio-active molecules is established, and the United States Food and Drug Administration approved the first deuterated drug, deutetetrabenazine, in 2017. Several other deuterated versions of common drugs are currently in phase II and III clinical trials. This proposal outlines our plan to undertake a market study in conjunction with UBC's University Industry Liaison Office and Adventus Research Consultants (Guelph, ON) to better understand the market potential of our invention. This study will encompass both primary and secondary research. The final deliverable will be a report from Adventus that informs our commercialization strategy as we develop the technology.